Kratom is a complex botanical with both opioid-like and stimulant properties, increasingly used in the U.S. for self-management of pain, as an opioid substitute, and for various mental health symptoms. While traditionally consumed for centuries in its natural form in its indigenous regions, commercially available kratom products in the U.S. are often variable in composition […]

This comprehensive 4-part webinar series is designed to strengthen Nevada’s approach to opioid and other substance use disorders, with special emphasis on maternal health and family systems. The series provides participants with data, tools, and real-world perspectives to improve prevention, treatment, and recovery supports across the lifespan. Series Schedule  (Wednesdays from 12–2 pm PT): November […]

Join us for a community health fair to help build community resilience by connecting people with local assistance and raising awareness about the value of preventive health. Participating vendors: Managed Care Health Plans Nevada Office of Suicide Prevention Nevada Division of Public and Behavioral Health Company Xceleration Overdose education & Naloxone information Nye Community Coalition […]

Join us for a five-part virtual follow-up series building on the in-person conference Supporting Pregnant and Parenting People Who Use Substances: Moving Toward Compassionate Care. Each one-hour session will take a deeper look at the health and well-being of parents, infants, and families affected by substance use disorder (SUD) and opioid use disorder (OUD). Series […]

This 90-minute virtual webinar introduces participants to core concepts and practical tools for addressing unhealthy alcohol and drug use in their service settings. Designed for Community Health Workers and other professionals in primary care and other health and mental health settings, the session will blend foundational knowledge with real-world applications. Participants will explore the spectrum […]

Substance use disorders are common in the United States, with 2024 data indicating that more than 1 in 4 (25.5%) of persons 12 years of age or older used an illicit drug in the past year. The availability of highly effective direct-acting antiviral (DAA) medications has radically changed the assessment and consideration of substance use, […]